Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Targeted Drug ROS1 Inhibitors for NSCLC Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Drug ROS1 Inhibitors for NSCLC Overall Market Size
2.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size: 2021 VS 2028
2.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Drug ROS1 Inhibitors for NSCLC Players in Global Market
3.2 Top Global Targeted Drug ROS1 Inhibitors for NSCLC Companies Ranked by Revenue
3.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue by Companies
3.4 Top 3 and Top 5 Targeted Drug ROS1 Inhibitors for NSCLC Companies in Global Market, by Revenue in 2021
3.5 Global Companies Targeted Drug ROS1 Inhibitors for NSCLC Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Drug ROS1 Inhibitors for NSCLC Players in Global Market
3.6.1 List of Global Tier 1 Targeted Drug ROS1 Inhibitors for NSCLC Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Drug ROS1 Inhibitors for NSCLC Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Markets, 2021 & 2028
4.1.2 Crizotinib
4.1.3 Lorlatinib
4.1.4 Entrectinib
4.1.5 Other
4.2 By Type - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue & Forecasts
4.2.1 By Type - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2017-2022
4.2.2 By Type - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2023-2028
4.2.3 By Type - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2021 & 2028
5.1.2 Squamous Cell Carcinoma of NSCLC
5.1.3 Adenocarcinoma of NSCLC
5.1.4 Large Cell Carcinoma of NSCLC
5.2 By Application - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue & Forecasts
5.2.1 By Application - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2017-2022
5.2.2 By Application - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2023-2028
5.2.3 By Application - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2021 & 2028
6.2 By Region - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue & Forecasts
6.2.1 By Region - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2017-2022
6.2.2 By Region - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2023-2028
6.2.3 By Region - Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2017-2028
6.3.2 US Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.3.3 Canada Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.3.4 Mexico Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2017-2028
6.4.2 Germany Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.4.3 France Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.4.4 U.K. Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.4.5 Italy Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.4.6 Russia Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.4.7 Nordic Countries Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.4.8 Benelux Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2017-2028
6.5.2 China Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.5.3 Japan Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.5.4 South Korea Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.5.5 Southeast Asia Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.5.6 India Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2017-2028
6.6.2 Brazil Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.6.3 Argentina Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Revenue, 2017-2028
6.7.2 Turkey Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.7.3 Israel Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.7.4 Saudi Arabia Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
6.7.5 UAE Targeted Drug ROS1 Inhibitors for NSCLC Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Targeted Drug ROS1 Inhibitors for NSCLC Major Product Offerings
7.1.4 Roche Targeted Drug ROS1 Inhibitors for NSCLC Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Major Product Offerings
7.2.4 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Beacon Pharma Limited
7.3.1 Beacon Pharma Limited Corporate Summary
7.3.2 Beacon Pharma Limited Business Overview
7.3.3 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Major Product Offerings
7.3.4 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Revenue in Global Market (2017-2022)
7.3.5 Beacon Pharma Limited Key News
7.4 Drug International Limted
7.4.1 Drug International Limted Corporate Summary
7.4.2 Drug International Limted Business Overview
7.4.3 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Major Product Offerings
7.4.4 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Revenue in Global Market (2017-2022)
7.4.5 Drug International Limted Key News
7.5 Incepta Pharmaceuticals
7.5.1 Incepta Pharmaceuticals Corporate Summary
7.5.2 Incepta Pharmaceuticals Business Overview
7.5.3 Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Major Product Offerings
7.5.4 Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Revenue in Global Market (2017-2022)
7.5.5 Incepta Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer